53
Participants
Start Date
September 30, 2008
Primary Completion Date
December 31, 2009
Study Completion Date
December 31, 2009
Xyntha
Xyntha for on-demand treatment of bleeding episodes were according to investigator prescription during the 6 months observation period. The recovery assessed by determining the Factor VIII (FVIII) concentration (FVIII:C) levels in individual subjects at the initial and final visits. The dose of Xyntha for recovery assessments is: single 50 IU/kg (±5 IU/kg) IV bolus infusion. All Xyntha administrations occurred in the clinic (hospital).
Pfizer Investigational Site, Beijing
Pfizer Investigational Site, Shanghai
Pfizer Investigational Site, Suzhou
Pfizer Investigational Site, Heping District
Pfizer Investigational Site, Hangzhou
Pfizer Investigational Site, Guangzhou
Lead Sponsor
Pfizer
INDUSTRY